Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach

PURPOSE: A differential release fixed dose matrix tablet of amlodipine besylate (AML-B) and simvastatin (SIM) was formulated to enhance patient compliance. MATERIAL AND METHOD: In the first phase, release controlling parameters of AML-B and SIM granules were identified and in the second phase a fixe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwal, Ummarah, Mukhtar, Shahid, Waheed, Muzzamil, Mehreen, Arifa, Abbas, Nasir, Shamim, Rahat, Hussain, Khalid, Rasool, Fatima, Hussain, Amjad, Bukhari, Nadeem Irfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164448/
https://www.ncbi.nlm.nih.gov/pubmed/34079222
http://dx.doi.org/10.2147/DDDT.S240506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164448/
https://www.ncbi.nlm.nih.gov/pubmed/34079222
http://dx.doi.org/10.2147/DDDT.S240506

Ejemplares similares